Abstract
Cerebrolysin (Cere) is a peptidergic nootropic drug with neurotrophic properties which has been used to treat dementia and sequelae of stroke. Use of Cere prevents nuclear structural changes typical of apoptosis and significantly reduces the number of apoptotic cells after several apoptotic stimuli. Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) is a hereditary disease caused by mutations of the Notch3 gene encoding the Notch3 protein. Notch3 is involved in the regulation of apoptosis, modulating Fas-Ligand (Fas-L)- induced apoptosis. The aim of this study was to evaluate the in vitro protective effects of Cere against oxidative stress-induced apoptosis in cells from CADASIL patients. We used peripheral blood lymphocytes (PBLs) from 15 CADASIL patients (age range 34–70 years); 2-deoxy-D-ribose (dRib), a highly reducing sugar, was used as paradigm pro-apoptotic stimulus. Apoptosis was analyzed by flow cytometry and fluorescence microscopy. Administration of Cere to PBLs from CADASIL patients cultured under standard conditions had no effect on the percentage of apoptotic cells. Administration of Cere to PBLs cultured with dRib caused a significant decrease in apoptosis after 48 h of culture in only 5 patients, whereas in the other 10 patients, Cere treatment was not associated with any significant difference in the percentage of apoptosis. This result showed a protective effect of Cere against oxidative stress-induced apoptosis only in 30 % of the CADASIL patients, suggesting that the Notch3 gene probably does not influence the anti-apoptotic properties of Cere in vitro.
References
Wei ZH, He QB, Wang H, Su BH, Chen HZ (2007) Meta-analysis: the efficacy of nootropic agent cerebrolysin in the treatment of Alzheimer’s disease. J Neural Transm 114:629–634
Hartbauer M, Hutter-Paier B, Skofitsch G, Windisch M (2001) Antiapoptotic effects of the peptidergic drug cerebrolysin on primary cultures of embryonic chick cortical neurons. J Neural Transm 108:459–473
Tournier-Lasserve E, Joutel A, Melki J, Weissenbach J, Lathrop GM, Chabriat H, Mas JL, Nibbio A, Cabanis EA, Baudrimont M, Maciazek J, Bach MA, Bousser MG (1993) Cerebral autosomal-dominant arteriopathy with sucortical infarcts maps to chromosome-19q12. Am J Human Genet 53:1091–1091
Formichi P, Radi E, Battisti C, Di Maio G, Tarquini E, Leonini A, Di Stefano A, Dotti MT, Federico A (2009) Apoptosis in CADASIL: an in vitro study of lymphocytes and fibroblasts from a cohort of Italian patients. J Cell Physiol 219:494–502
Formichi P, Battisti C, Tripodi SA, Tosi P, Federico A (2000) Apoptotic response and cell cycle transition in ataxia telangiectasia cells exposed to oxidative stress. Life Sci 66:1893–1903
Acknowledgments
This work was supported by Ever Neuro Pharma GmbH (Unterach, Austria) (grant to AF).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Formichi, P., Radi, E., Battisti, C. et al. Effects of cerebrolysin administration on oxidative stress-induced apoptosis in lymphocytes from CADASIL patients. Neurol Sci 34, 553–556 (2013). https://doi.org/10.1007/s10072-012-1174-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-012-1174-y